click below
click below
Normal Size Small Size show me how
pht 100 c93
chapter 9 part 3
Question | Answer |
---|---|
the iv admixture services in most hospitals share | iv antibiotics, thrombolytics, nutrition, & cancer chemotherapy |
the iv admixture services are staffed by | specially trained pharmacists/techs |
the iv admixture services are centralized pharm] services that | prepares iv & tpn solution in a sterile, germ-free work environment |
total parenteral nutrition service are in | many hospitals |
a tpn is | a total parenteral nutrition service |
tpn services have trained/certified | techs, pharmacists, nurses, nutritionists & physicians |
the tpn service is for | patients who can't eat |
the tpn is a special formulated | parenteral solution with nutrients |
in the tpn & iv admixtures, large hospitals | use automation |
the automation for tpn & iv admixtures allows pharm ] to efficiently | operate, minimizes med errors, & reduces inventory |
tech errors must be watched eventhough | automation reduces errors |
a med. administration record is | the MAR |
MAR's record any | med. administration |
MAR's are patient specific & includes | med. orders, drug names, doses, administration routes & times, start & stop dates, and special instruction |
the MAR is a form in the | patient med. chart used by nurses |
MAR's cam be electronic which is | eMAR |
med. orders are input in | hand held computer & sent to pharm]s |
patient info. is scanned from | barcode on wristband |
to units, pharm]s | check, fills, & sends meds |
eMAR documents patients administer drugs using | barcode technology |
many committees support | functions of hospitals |
pharm] hospital functions include | pharm] & therapeutics, infection control, & institutional review board |
a tech represents a department on | the committees |
the pharm] & the therapeutic committee reviews, approves, & revises | hospital formularies & keeps drug use policies in hospital |
the pharm] & therapeutic committee has | medical staff , administrators, pharm] director, & drug info. pharmacist |
a medical staff can apply to a P&T committee to have | a new drug added to the formulary |
the new drug is compared with the existing formulary in terms of | costs, advantages, and advantages |
the application is considered by the | full committee |
the institutional review board is a committee ensuring protection is provided to patients using | investigational drugs; otherwise known as human use committee |
the IRB is the | institutional review board |
the IRB is charged with ensuring patient safety interns of | investigational drugs, procedures, or other clinical research studies |
the IRB has consumer representatives & members of | medicine, pharm], nursing, & hospital administration |
investigational drugs are drugs used in | clinical trials not yet approved by FDA for general use |
the investigator/researcher submits an application to | the IRB outlining study of number, age, & type of subjects & informed consent forms to be used |
the IRB protects patients by assuming knowledge of | risks & confidentiality of the medical information collected |
informed consent is written permission by a patient to participate in an | IRB approved research study to understand the lay public |